249647-25-4

Basic information

• Product Name: 3-bromo-4-iodobenzoic acid
• Synonyms: 3-bromo-4-iodobenzoic acid
• CAS NO: 249647-25-4
• Molecular Formula: C₇H₄BrIO₂
• Molecular Weight: 326.91393
• Product Categories: Acids & Esters;Bromine Compounds;Iodine Compounds
• Mol File: 249647-25-4.mol

Chemical Properties

• Melting Point: 242-243℃
• Appearance: /
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• CAS DataBase Reference: 3-bromo-4-iodobenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-bromo-4-iodobenzoic acid(249647-25-4)
• EPA Substance Registry System: 3-bromo-4-iodobenzoic acid(249647-25-4)

Safety Data

• Hazardous Substances Data: 249647-25-4(Hazardous Substances Data)

Usage

Chemical Properties

White powder

Upstream product

• 873387-82-7 3-bromo-4-iodobenzaldehyde 
• 289039-23-2 2-bromo-4-ethyl-1-iodobenzene 
• 249647-24-3 3-bromo-4-iodobenzoic acid methyl ester 
• 619-44-3 methyl 4-iodobenzoate 
• 101420-88-6 4-iodo-3-nitrobenzaldehyde 
• 15164-44-0 p-(iodophenyl)carboxaldehyde 
• 100-41-4 ethylbenzene 
• 25309-64-2 4-ethyl-1-iodobenzene 
• 94-09-7 p-aminoethylbenzoate 
• 386267-31-8 ethyl 3-bromo-4-iodobenzoate 
• 619-58-9 4-iodobenzoic acid 

Downstream Products

• 249647-26-5 (3-bromo-4-iodophenyl)methanol 
• 1374636-43-7 tert-butyl 3-bromo-4-iodobenzoate 
• 1374636-47-1 C₂₂H₂₄Br₂O₄S₂ 
• 1374636-52-8 tert-butyl 3-bromo-4-((phenylsulfonyl)thio)benzoate 
• 1374636-58-4 tert-butyl 3-bromo-4-(((trimethylsilyl)ethynyl)thio)benzoate 
• 1374636-86-8 tert-butyl 3-bromo-4-((3-((triisopropylsilyl)oxy)prop-1-yn-1-yl)thio)benzoate 
• 1369483-90-8 5-(5-{2-[5-(3-bromo-4-iodophenyl)-1,2,4-oxadiazol-3-yl]-3-methylbutan-2-yl}pyridin-2-yl)pyrimidin-2-amine 
• 1671080-26-4 2-(diphenylphosphoryl)-[1,1'-biphenyl]-4,4'-dicarboxylic acid 

Relevant articles and documents

Selective catalytic behavior of a phosphine-tagged metal-organic framework organocatalyst

Steric hindrance by a metal-organic framework (MOF) is shown to influence the outcome of a catalytic reaction by controlling the orientation of its intermediates. This is demonstrated using an organocatalyst, phosphine MOF LSK-3, which is evaluated with t

Synthesis of functionalized benzo[b]thiophenes by the intramolecular copper-catalyzed carbomagnesiation of alkynyl(aryl)thioethers

Highly functional: A copper(I)-catalyzed intramolecular carbomagnesiation under mild conditions transforms readily available alkynyl(aryl)thioethers into magnesiated benzothiophenes. Subsequent reaction with various electrophiles (acid chlorides, allyl bromides, aryl halides) provides polyfunctional benzo[b]thiophenes (see scheme). Further modification of the cyclization products affords highly diversified benzothiophene derivatives and new heterocyclic scaffolds.

BIS-(SULFONYLAMINO) DERIVATIVES IN THERAPY 065

The invention provides compounds of formula wherein R1, R2, R3, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1

BIS-(SULFONYLAMINO) DERIVATIVES IN THERAPY 066

The invention provides compounds of formula wherein R1, R3, L1, L2, G1, G2, A and m are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with processes for their preparation, pharmaceutical compositions containing them and their use in therapy. The compounds are inhibitors of microsomal prostaglandin E synthase-1.

Discovery of potent and selective SH2 inhibitors of the tyrosine kinase ZAP-70

A series of 1,2,4-oxadiazole analogues has been shown to be potent and selective SH2 inhibitors of the tyrosine kinase ZAP-70, a potential therapeutic target for immune suppression. These compounds typically are 200- 400-fold more potent than the native,